Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.

Source:http://linkedlifedata.com/resource/pubmed/id/21555592

Proc. Natl. Acad. Sci. U.S.A. 2011 May 24 108 21 8785-90

Download in:

View as

Triples

General Info

PMID
21555592